email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
931 - 945
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Nuance Pharma Acquires Rights to Nasal Spray in $23.5 Million Deal
$5.00
Available
InxMed Raises $50 Million for Resistance-Fighting Cancer Therapies
$5.00
Available
OBiO Signs MOU to Manufacture Cell Therapy for Korea's Eutilex
$5.00
Available
Haisco In-Licenses Oral Film Version of Riluzole for ALS
$5.00
Available
Adagene to Add Masking Technology to 4 Sanofi Candidates in $2.5 Billion Deal
$5.00
Available
Zhongze In-licenses CNS Candidate for Schizophrenia and Parkinson's
$5.00
Available
Legend-Janssen CAR-T Therapy Approved in US for Multiple Myeloma
$5.00
Available
AnHeart-Innovent Granted China Breakthrough Status for NSCLC Drug
$5.00
Available
Huadong Strikes $1 Billion Deal for Asia Rights to Four ADC Candidates
$5.00
Available
Transcenta Starts Phase II Trial of Claudin18.2 Therapy for Biliary Tract Cancer
$5.00
Available
CANbridge to Launch Rare Disease Therapy in China's Medical Tourism Zone
$5.00
Available
Simcere Reports Anti-Neutropenia Oncology Drug Meets Phase III Endpoint
$5.00
Available
Huadong Pharma Forms $662 Million Collaboration for Anti-Inflammatory Drugs
$5.00
Available
Lepu Completes $116 Million HK IPO; Trades Flat in Opening Sessions
$5.00
Available
Sirnaomics Says siRNA Effective in Phase II Basal Cell Carcinoma Trial
$5.00
Available